UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH

umeclidinium bromide and vilanterol trifenatate
$4.8778per EA

Strength

62.5; 25 ug/1; ug/1

NDC

66993013497

Classification

Generic

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA203975

On Market Since

4/11/2025

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

-0.8%

3M

-2.0%

6M

-1.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

+4.8%